Windtree Therapeutics Secures $857,000 Convertible Note Financing for CommLoan Acquisition

Reuters12-03
Windtree <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Secures $857,000 Convertible Note Financing for CommLoan Acquisition

Windtree Therapeutics Inc. has entered into a new debt financing agreement, issuing senior convertible promissory notes with an aggregate principal amount of $857,142.86 to an institutional investor. The notes, maturing on November 26, 2026, bear interest at 10% per annum and were issued in connection with Windtree's planned acquisition of CommLoan Inc. Proceeds from the notes will be used to advance $450,000 to CommLoan and retain $150,000 for general corporate purposes. The agreement includes mandatory prepayment provisions and a prepayment premium, as well as a beneficial ownership limitation of 4.99% for the investor.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Windtree Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-036665), on December 02, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment